Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Diagnostic Labeling of COPD in Five Latin American Cities
2007
Defining the Minimum Level of Detectable Change for the Roland-Morris Questionnaire
1996
Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
1997
The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
2003
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
2001
Interpreting COPD Prevalence Estimates
2003
Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature
2006
Varicella Vaccination of Immunocompromised Children
2008
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
CLINICAL TRIALS IN IMMUNOCOMPROMISED INDIVIDUALS
1996
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Persistence of Immunity to Varicella in Children with Leukemia Immunized with Live Attenuated Varicella Vaccine
1989
Interpreting and Reporting Results Based on Patient-Reported Outcomes
2007
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Not 15 But 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies
2003
Global burden of COPD: systematic review and meta-analysis
2006
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
2002
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Animal models of chronic obstructive pulmonary disease
2008
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
2001
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Chronic obstructive pulmonary disease: current burden and future projections
2006
Quality of life bibliography and indexes: 1993 update
1995
The metabolic syndrome
2010 Standout
The Proportional Venn Diagram of Obstructive Lung Disease*
2003
Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey
2005
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Contemporary Management of Chronic Obstructive Pulmonary Disease
2003
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
2000
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy–Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches
2005
Administration of Live Varicella Vaccine to HIV‐Infected Children with Current or Past Significant Depression of CD4+T Cells
2006
Uric Acid and Cardiovascular Risk
2008 Standout
COPD: can prevention be improved? Proposal for an integrated intervention strategy
2004
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Interpreting the significance of changes in health-related quality-of-life scores.
1998 Standout
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
2009
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Epidemiologic Evidence on the Association Between Peptic Ulceration and Antiinflammatory Drug Use
1989
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly Persons
1988
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample
2006
Pneumococcal Vaccine Response in Cirrhosis and Liver Transplantation
2000
Enzyme Replacement Therapy in Fabry Disease
2001 Standout
Treatment of osteoporosis with denosumab
2010
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Costs of Chronic Bronchitis and COPDa
2003
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy
2005
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
1991 Standout
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening
2002
Methods to Explain the Clinical Significance of Health Status Measures
2002
Defining clinically meaningful change in health-related quality of life
2003
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
2007 Standout
The burden of COPD in Italy: results from the confronting COPD survey
2003
Alzheimer's Disease
2010 Standout
Immunization of HIV-infected children with varicella vaccine
2001
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments
2001
Response to HBV vaccination in patients with severe liver disease
1992
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Potential misclassification of causes of death from COPD
2006
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Epidemiology and costs of chronic obstructive pulmonary disease
2005
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD
2003
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Estimating clinically significant differences in quality of life outcomes
2005
COPD in Japan: the Nippon COPD Epidemiology study
2004
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD
2004
Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly Persons
1991
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
The occupational burden of chronic obstructive pulmonary disease
2003
Validation of pharmacy records in drug exposure assessment
1997
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Pulmonary Rehabilitation
2007
Linking Clinical Relevance and Statistical significance in Evaluating Intra-Individual Changes in Health-Related Quality of Life
1999
The Incidence of Zoster after Immunization with Live Attenuated Varicella Vaccine
1991
Adherence to Medication
2005 Standout
Prevalence of Chronic Obstructive Pulmonary Disease in Korea
2005
American Thoracic Society Statement
2003 Standout
Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Clinical, Radiologic, and Induced Sputum Features of Chronic Obstructive Pulmonary Disease in Nonsmokers
2002
Addition of Rosiglitazone to Existing Sulfonylurea Treatment in Chinese Patients with Type 2 Diabetes and Exposure to Hepatitis B or C
2003
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1996
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
LIVE ATTENUATED VARICELLA VACCINE
1996
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Gastrointestinal Bleeding from the Nonsteroidal Anti — Inflammatory Drugs
1990
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
2001
IARC Handbooks of Cancer Prevention
2003
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk and Cost of Gastrointestinal Side Effects Associated With Nonsteroidal Anti-inflammatory Drugs
1989
Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences
2005
Interpretation of Quality-of-Life Outcomes
2000
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
2002
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Mechanisms of cigarette smoke-induced COPD: insights from animal models
2008
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
What are minimal important changes for asthma measures in a clinical trial?
1999
Works of Eva Lydick being referenced
Pneumococcal Vaccination: The Response of Patients with Alcoholic Liver Cirrhosis
1984
The case for unstable angina pectoris as a primary end point in primary prevention studies
1992
The Prevalence of COPD
2000
Compliance with pharmacologic therapy for osteoporosis
2003
Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes
2000
Interpretation of quality of life changes
1993
Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine
1989
Obstructive Lung Disease and Low Lung Function in Adults in the United States
2000
Area under the curve: A metric for patient subjective responses in episodic diseases
1995
Community impact of childhood varicella infections
1997
Predicting the costs of managing patients with chronic obstructive pulmonary disease
2005
Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983
1988
The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults
2001
Compliance of Women in Taking Estrogen Replacement Therapy
1996
EXACT BINOMIAL CONFIDENCE INTERVALS FOR THE RELATIVE RISK IN FOLLOW-UP STUDIES WITH SPARSELY STRATIFIED INCIDENCE DENSITY DATA1
1987
Risk of Herpes Zoster in Children With Leukemia: Varicella Vaccine Compared With History of Chickenpox
1986
Long-Term Absolute Benefit of Lowering Blood Pressure in Hypertensive Patients According to the JNC VI Risk Stratification
2000
Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density.
1998